Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gene Therapy Oversight To Be Streamlined By US FDA, NIH

Aug 02 2018

• By Derrick Gingery

Decorin protein

Related Content

Gene Therapy 'Cassettes' Could Speed, Cheapen Manufacturing, Gottlieb Says

May 24 2018

Gene Therapy Guidances From US FDA Coming In About 6 Weeks, Gottlieb Says

May 11 2018

Sarepta Learns Why Earlier GMP Control Is Better For Promising Gene Therapies

Jul 29 2018

Gene Therapies Need Long-Term Follow-Up Plan From Outset Or Risk Clinical Hold

Jul 12 2018

CBER Implements Pre-Clinical Meeting Program For Biologics, Gene Therapy Sponsors

Jun 22 2018

Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

Jun 20 2018

Related Companies

Sarepta Therapeutics, Inc.

Additional Topics

United States Biologics Regenerative Medicine Regulation FDA BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window